Log in

Intercept Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:ICPT)

-3.01 (-3.02 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
Now: $96.65
50-Day Range
MA: $114.74
52-Week Range
Now: $96.65
Volume574,039 shs
Average Volume598,317 shs
Market Capitalization$3.16 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Intercept Pharmaceuticals (NASDAQ:ICPT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
20 Wall Street analysts have issued ratings and price targets for Intercept Pharmaceuticals in the last 12 months. Their average twelve-month price target is $145.79, suggesting that the stock has a possible upside of 50.84%. The high price target for ICPT is $257.00 and the low price target for ICPT is $68.00. There are currently 2 sell ratings, 4 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.652.712.702.64
Ratings Breakdown: 2 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
2 Sell Rating(s)
3 Hold Rating(s)
15 Buy Rating(s)
1 Strong Buy Rating(s)
2 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
1 Strong Buy Rating(s)
2 Sell Rating(s)
4 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $145.79$141.00$131.00$145.29
Price Target Upside: 50.84% upside17.96% upside101.32% upside83.95% upside

Intercept Pharmaceuticals (NASDAQ:ICPT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Intercept Pharmaceuticals (NASDAQ:ICPT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/22/2020WedbushReiterated RatingBuy$257.00Medium
1/9/2020B. RileyBoost Price TargetBuy$133.00 ➝ $158.00Low
1/2/2020Svb LeerinkReiterated RatingUnderperformMedium
1/2/2020CitigroupDowngradeBuy ➝ Neutral$85.00 ➝ $140.00High
12/17/2019Robert W. BairdReiterated RatingBuy$227.00Low
12/17/2019Needham & Company LLCReiterated RatingBuy$150.00Low
12/17/2019Credit Suisse GroupReiterated RatingOutperform$87.00 ➝ $141.00Low
12/17/2019Wells Fargo & CoReiterated RatingPositive ➝ Overweight$120.00 ➝ $146.00Low
12/2/2019Canaccord GenuityInitiated CoverageBuyMedium
11/25/2019Stifel NicolausBoost Price Target$86.00 ➝ $102.00High
10/21/2019Raymond JamesLower Price TargetStrong-Buy$148.00 ➝ $147.00High
10/18/2019Jefferies Financial GroupSet Price TargetBuy$125.00High
9/6/2019Royal Bank of CanadaSet Price TargetBuy$135.00Medium
8/8/2019Cantor FitzgeraldLower Price TargetOverweight$191.00 ➝ $186.00High
8/6/2019OppenheimerLower Price TargetOutperform$170.00 ➝ $160.00Medium
5/8/2019CowenReiterated RatingBuy$149.00Medium
3/28/2019UBS GroupBoost Price TargetBuy$139.00Low
2/22/2019Leerink SwannDowngradeOutperform ➝ Market Perform$70.00Medium
2/20/2019JMP SecuritiesBoost Price TargetOutperform ➝ In-Line$175.00 ➝ $200.00High
2/15/2019Bank of AmericaReiterated RatingUnderperform$68.00Low
1/14/2019LaidlawUpgradeHold ➝ Buy$99.00 ➝ $130.00Low
11/19/2018CIBCUpgradeMarket Perform ➝ OutperformMedium
9/12/2018Roth CapitalInitiated CoverageBuy ➝ Buy$192.00Low
8/6/2018Goldman Sachs GroupUpgradeSell ➝ Buy$46.00 ➝ $157.00High
2/15/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$152.00 ➝ $155.00High
2/12/2018Deutsche BankInitiated CoverageBuy$103.00Medium
(Data available from 1/25/2018 forward)
This page was last updated on 1/25/2020 by MarketBeat.com Staff

Featured Article: Cryptocurrencies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel